uniQure (QURE) Change in Accured Expenses (2016 - 2026)
uniQure (QURE) posted quarterly Change in Accured Expenses of $7.2 million for Q2 2026, up 446.69% year-over-year from $1.3 million in Q2 2025, and up 83.84% quarter-over-quarter from $3.9 million in Q1 2026.
Analysis
uniQure (QURE) Change in Accured Expenses (2016 - 2026) Analysis & Trends
uniQure's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $7.2 million for Q2 2026.
- In Q2 2026, Change in Accured Expenses rose 446.69% year-over-year to $7.2 million; the TTM figure through Jun 2026 stood at $18.8 million (up 610.59% YoY), while the FY2025 annual figure was $4.5 million, up 179.3% from the prior year.
- Change in Accured Expenses for Q2 2026 stood at $7.2 million, up from $3.9 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $22.6 million in Q3 2025, with the low at -$14.8 million in Q4 2025.
- The 5-year median for Change in Accured Expenses is $215500.0 (2022), against an average of $441833.3.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 682.77% in 2024, then jumped 537.32% in 2025.
- uniQure's Change in Accured Expenses stood at -$248000.0 in 2022, then soared by 373.79% to $679000.0 in 2023, then plunged by 682.77% to -$4.0 million in 2024, then sank by 275.21% to -$14.8 million in 2025, then jumped by 148.27% to $7.2 million in 2026.
- Business Quant data shows QURE's Change in Accured Expenses at $7.2 million in Q2 2026, $3.9 million in Q1 2026, and -$14.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 7.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.17 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | -14.85 Mn |
| Sep 30, 2025 | 22.59 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -3.96 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | -8.11 Mn |
| Dec 31, 2023 | 679,000.00 |
| Sep 30, 2023 | 5.41 Mn |
| Jun 30, 2023 | -2.41 Mn |
| Mar 31, 2023 | -9.01 Mn |
| Dec 31, 2022 | -248,000.00 |
| Sep 30, 2022 | 4.93 Mn |
| Jun 30, 2022 | 4.78 Mn |
| Mar 31, 2022 | -6.08 Mn |
| Dec 31, 2021 | -2.39 Mn |
| Sep 30, 2021 | 6.11 Mn |